Inventor · disambiguated record
Tadashi Shimamura
Also filed as: SHIMAMURA TADASHI
17 granted patents·5 pending applications·20 citations·filing 2005–2020
89Inventor score
Top patents by PatentIndex Score
22 records- 0193US10155768B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 18, 2018·8 cites·9 claims
- 0283US12037345B2Heterobicyclic compounds for inhibiting the activity of SHP2TAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jul 16, 2024·2 cites·19 claims
- 0377US9650386B2Quinoline-substituted compoundTAIHO PHARMACEUTICAL CO LTD·Filed 2014·Granted May 16, 2017·3 cites·15 claims
- 0475US10233189B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 19, 2019·1 cites·20 claims
- 0574US9758526B2Quinoline-substituted compoundTAIHO PHARMACEUTICAL CO LTD·Filed 2016·Granted Sep 12, 2017·1 cites·10 claims
- 0674US7709475B2Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeletonBANYU PHARMA CO LTD·Filed 2005·Granted May 4, 2010·2 cites·11 claims
- 0772US8093389B2Substituted spirochromanone derivativesIINO TOMOHARU·Filed 2008·Granted Jan 10, 2012·2 cites·15 claims
- 0871US10787457B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 29, 2020·0 cites·3 claims
- 0969US11014930B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted May 25, 2021·0 cites·21 claims
- 1068US11236096B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 1, 2022·0 cites·8 claims
- 1165US11046696B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted Jun 29, 2021·0 cites·7 claims
- 1265US8362052B2Isoindolin-1-one derivativeMSD KK·Filed 2010·Granted Jan 29, 2013·1 cites·11 claims
- 1363US10807986B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 20, 2020·0 cites·7 claims
- 1459US9845329B2Method for producing a substituted 6,7,8,9-tetrahydropyrimido[5,4-b]indolizine, substituted 7,8,9,10-tetrahydro-6H-pyrimido[5′,4′:4,5]pyrrolo[1,2-a]azepine and substituted 6,7,8,9,10,11-hexahydropyrimido[5′,4′:4,5]pyrrolo[1,2-a]azocineTAIHO PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 19, 2017·0 cites·7 claims
- 1556US12215109B2Crystal of pyrazolo[3,4-d]pyrimidineTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 4, 2025·0 cites·8 claims
- 1656US2018086770A1Method for producng tricyclic compound, and tricyclic compound capable of being produced by said production methodTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 1753US12458640B2Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitorsOTSUKA PHARMA CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·33 claims
- 1845US8138197B2Spirochromanon derivativesIINO TOMOHARU·Filed 2008·Granted Mar 20, 2012·0 cites·3 claims
- 1944US2011065739A1Novel isoxazole drivativeISHIKAWA MAKOTO·Filed 2009·Application pending·0 cites
- 2033US2011275647A1Pyrimidin-4-(3h)-one derivativesMSD KK·Filed 2010·Application pending·0 cites
- 2132US2012015938A11,4-benzodiazepin-2-on derivativesASAI MASANORI·Filed 2010·Application pending·0 cites
- 2232US2011319396A1Benzodiazepin-2-on derivativesASAI MASANORI·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →